(lp0
S"Analyst rating score stands at 2.30 while Verastem, Inc.'s  stock price ... Hot Stocks Point - 7 hours ago Verastem, Inc.  ended its day with gain 2.74% and finalized at the price of $1.50. During its last trading session, Stock traded with the total exchanged volume of 0.69 million shares."
p1
aS'Verastem to Host Conference Call on March 23rd to Discuss Fourth Quarter and ... Yahoo Finance - Mar 16, 2017 Verastem, Inc. , focused on discovering and developing drugs to treat cancer, today announced that the Company will host a conference call and webcast on Thursday, March 23, 2017 at 4:30 p.m.Which analysts are covering Verastem, Inc. ? - Post AnalystConsensus Notes on Verastem, Inc.  - Rockville Register'
p2
aS'Verastem shares plunge as drug trial fails The Boston Globe - Sep 28, 2015 Shares of Verastem Inc. plummeted 67.4 percent Monday after the Cambridge biotech reported that its lead drug candidate failed to help patients suffering from a rare form of lung cancer.Verastem stops cancer therapy development; shares plunge - ReutersVerastem Stops Enrollment Due to Futility in the COMMAND Study of VS-6063 for ... - Business Wire '
p3
aS"Earnings Clues on Innoviva, Inc. , Verastem, Inc.  Analyst's ... StockNewsJournal - Mar 14, 2017 Verastem, Inc. , maintained return on investment for the last twelve months at -37.47, higher than what Reuters data shows regarding industry's average.Stock On the Run: Verastem, Inc.  - HugoPressStocks in the Spotlight: Verastem, Inc.  , Nuveen Dividend ... - NYSE Journal "
p4
aS'Verastem to Present at the 29th Annual ROTH Conference Yahoo Finance - Mar 7, 2017 Verastem, Inc. , focused on discovering and developing drugs to treat cancer, today announced that the company will present at the 29th Annual ROTH Conference on Monday, March 13th at 4:00 p.m. PT at the Ritz Carlton in Dana Point, CA.'
p5
aS'Is this Large Market Cap Stock target price reasonable for Verastem, Inc ... The Daily Leicester - 19 hours ago The company in question is, Verastem, Inc.  currently with a stock price of 1.57 . The market cap for Verastem, Inc. is 54.4, and is in the sector Healthcare, and Biotechnology industry. The target price for Verastem, Inc. is ...'
p6
aS'Verastem Names Gregory I. Berk, MD as Chief Medical Officer Business Wire  - Apr 18, 2016 BOSTON----Verastem, Inc. , focused on discovering and developing drugs to treat cancer, today announced the appointment of Gregory I. Berk, MD as Chief Medical Officer.'
p7
aS"Recent Trading Alert: Verastem, Inc.  Is stories - Mar 16, 2017 Verastem, Inc.'s  witnessed a gain of 5.11% in recent trading period with closing price of $ 1.44. The company's last traded volume of 0.29 million shares as compared to it's an average volume of 0.21 million shares."
p8
aS'Technical Clues For Verastem, Inc.  Investors USA Commerce Daily - Mar 14, 2017 With all other things going on, Verastem, Inc.  has been on a run - rising 32.76 percent in just three months.'
p9
aS'Annual BIO CEO &amp; Investor Conference Business Wire  - Jan 26, 2017 BOSTON----Verastem, Inc. , focused on discovering and developing drugs to treat cancer, today announced that the company will present at the 19th Annual BIO CEO &amp; Investor Conference on Tuesday, February 14th at&nbsp;...'
p10
a.